Illumina, a leader in DNA sequencing technology, will announce its third quarter 2026 financial results after market close on October 29, 2026. On the same day, CEO Jacob Thaysen and CFO Ankur Dhingra will hold a conference call at 1:30 pm Pacific Time to discuss the results with investors and analysts. The call will be accessible via a live webcast on Illumina's website and a replay will be available for 30 days. This event is important for investors to understand the company's recent performance and outlook in the genomics industry.
Illumina shares are currently priced at USD 263.84 on Pluang as of October 9, 2026, showing a 1.46% decrease in one day. The company holds a market capitalization of $40.43 billion, reflecting its significant presence in the health sector. Investor interest remains strong with 96% of Pluang orders being buys, indicating confidence ahead of the upcoming earnings announcement on October 29, 2026.
